DatasetName,BCL11B_S(102) BCL11B_S(129) BCL11B_S(247) BCL11B_S(310) BCL11B_S(425) BCL11B_S(426) BCL11B_S(607) BCL11B_S(671) BCL11B_S(678) BCL11B_S(701) BCL11B_S(704) BCL11B_S(91) BCL11B_S(97) BCL11B_T(242) BCL11B_T(305) BCL11B_T(705) BCL11B_T(754),BCL11B_S(309) BCL11B_S(330) BCL11B_S(368) BCL11B_S(381) BCL11B_S(398) BCL11B_S(417) BCL11B_S(422) BCL11B_S(496) BCL11B_S(497) BCL11B_S(673) BCL11B_S(753) BCL11B_S(772) BCL11B_T(247) BCL11B_T(260) BCL11B_T(309) BCL11B_T(313) BCL11B_T(346) BCL11B_T(376) BCL11B_T(417) BCL11B_T(751),BCL11B_S(318) BCL11B_S(375)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,0.6224734228641645,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.595164523081232,0.3949849081544835,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,0.5949565662294762,0.4067210975358494,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,,,
WZ2023_Pu_010_30min,0.5969833928458242,0.40512761666384944,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,0.4080880503875691,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.5967370093122935,0.42335731696580153,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,0.5906986541319554,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.5951281701244986,0.40424446536724734,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,0.5978722770912387,0.40529727051992087,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.5965362570306427,0.40435955301132126,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.5974419756271827,0.4037147569186773,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.5970249573869768,0.4048500986520421,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,
CR2017_Ratio Replicate 1.3,0.5972585430254107,0.40786801270917933,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,0.39761370026210824,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,0.40506374988531724,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,,
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.5887821687861154,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.5960991419560733,0.404307013683402,
CK2022_11 40-1,0.5979945542431572,0.40407458868275825,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,0.40708047143817117,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,,,
WZ2023_Pu_005_20min,0.5968265446001082,0.4048983983306032,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,0.5913116754700787,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.5921623027857478,0.39405427271966625,
CK2022_1 200-1,0.5996515393224666,0.39933097737099255,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,,
RCJD2014_5min_1,0.6121340478990029,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5997802164235416,0.40126149780502074,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,,
KBE2022_Log2_Ex_8_T,,0.40545992474719156,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,0.5954714927023466,0.404112665345082,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,,0.40164412727113846,
HH2022_Reporter intensity 8,0.588379137532594,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,0.40712021999725223,
EJN2021_5_Rest_Basal,,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,0.39842532432150285,
YA2020_Reporter_intensity_Normal_No.1,,0.3939658726029957,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.5949550640851264,,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,,
HS2024_8_I_T3,,,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.5966721277721957,0.40469036212345344,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.5945145535469639,0.4045327972123049,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,0.5956815648501858,0.39506283020301397,
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,,,
RAM2015_Log2 A,,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,,0.39855922120438114,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.5898238937417385,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,0.5955517676032485,0.4065479517465923,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,,0.40544493729131414,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.5886627093746081,0.4039173065340149,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,0.6046798623800075,0.41202973025478834,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,0.39655207539779613,
EJN2021_4_Rest_Ins,,,
RN2012_H05,,0.4080081707462796,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,
HH2022_Reporter intensity 3,0.6072373364378505,0.4083332353492641,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,0.4090653887465402,
JW2021_After_3,,,
GF2025_P8_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,0.40950804735188695,
CK2022_11 200-1,0.5986372144821375,0.40521679764135793,
CK2022_12 200-1,0.5991079684252628,0.4046238431084951,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.5921732901418347,0.40996195244443934,
WZ2023_Su_010_20min,0.59649640917593,0.40443066758164703,
AH2018_TMTMS2_2_N,0.5981716754198136,0.4241439397499363,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,
AH2018_TMTMS3_Pool,,0.4118022651627366,
KS2014_Intensity N4,,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.6191233295463506,0.43623417670359216,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,0.4110670029797473,
AST2020_anti-CD3+PDL2.2,0.5966316254163669,0.4071517816623033,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.6092146308047736,0.4156475992646434,
GF2025_P1_Adh,,,
GF2025_P1_Sph,,,
EJN2021_5_Ex_Basal,,,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.5961850024620474,0.40415658748399813,
CF2017_EOC 1,,,
CK2022_3 200-1,0.5987614623861317,0.3982889073783801,
AH2018_LFQ_IT_3_C,,0.410505768636381,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,0.5959467007084162,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.5960335341468668,0.4024867244272358,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.5985338941969406,0.39928214731782224,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.5945048712283122,0.39596168173127094,
AR2021_ALG 1 μM,,,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,0.5925692857185673,,
CR2017_Ratio Replicate 3.2,0.6000489416398348,0.40176568399955465,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,,
CK2022_9 16-1,0.5947484006800978,0.39506223596330786,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.6193958275654383,0.4383994225334355,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,0.607840918325477,0.4151280830394118,
FS2019_db/db3,,,
CK2022_15 40-1,0.6045141840979869,0.412622047031766,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.5968963437378443,0.4038914636550827,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,0.40705888872084095,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,,0.41072288313140887,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,0.4057876695354955,
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.5910377327432894,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,0.3989346490590446,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.5984385345629756,0.39907153327249756,
RN2012_L13,,0.39576235680018695,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,0.4049800767633503,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.596716974115312,0.40317740369765004,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,,
HH2022_Reporter intensity 6,0.5904293251904014,0.401974281293864,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.5968603958415111,0.42560090690455177,
GF2025_P3_Adh,,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,0.5975342875300047,0.4237710336004435,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,,
KBE2022_Log2_Ex_19_U,,0.40735496202344657,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,0.40673474373162355,
AST2020_Control,0.5937103609053098,0.403517799476507,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,0.5852604653823464,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,,0.3882409403115214,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,0.6020721916645106,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,0.6061653182068591,0.40757306358721357,
HH2022_Reporter intensity 2,0.606616989411751,0.4074242997522881,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,0.4059436979672076,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,0.608706942254599,,
EP2017_Untreated R#2 log2 ratio,,,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,0.6058045762192976,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,,
AR2021_KD 72h,,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,0.4141122482414855,
KBE2022_Log2_Ex_9_U,,,
AH2018_SILAC_M_3_N,,0.3992082898833981,
KBE2022_Log2_Ex_13_T,,0.40669774736982545,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,,,
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,0.3996179380677071,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.5946233796136279,0.4025666013247401,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,
TM2022_S2.12h.B,,,
RN2012_L15,0.6013339080576676,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.5941105517370975,0.39807780476125326,
CK2022_5 200-1,0.5940823413412142,0.3982961269296891,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,,0.399640110667003,
EJN2021_5_Rest_Ins,,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,0.5869578880641312,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,,
CK2022_4 16-1,0.5933742662474908,0.39134213111534877,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,,,
AH2018_SILAC_IT_2_N,,0.39579024616951003,
AH2018_SILAC_IT_1_X,,0.4062740366943144,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,,
WZ2023_Pe_025_20min,0.595368624883482,0.403972699482554,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.5962330135585904,0.42299865992134256,
RN2012_H06,0.6059714080340484,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.5969031553610071,0.40471280939747833,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5918877202262309,,
WZ2023_Su_025_10min,0.5969517089413017,0.4041943922306399,
AH2018_LFQ_IT_4_X,,0.3975840860394418,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.5965907856726568,0.40406788650003167,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,,,
RN2012_L10,,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,,0.40332558479157504,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,0.5909391228645802,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.5924798483753692,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.6171644697308578,0.4369122015186508,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,,
GF2025_P9_Sph,,,
CK2022_6 200-1,0.594647845514451,0.3989844817926331,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,0.412848943494617,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.5945287369761365,0.3981276655376399,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,0.41052028490631065,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,,,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.5887427446979133,,
EP2017_Untreated R#3 log2 ratio,,,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.5910446761444152,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,0.5995604375293997,0.4051649460277599,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,,
YA2020_Reporter_intensity_Normal_No.2,,0.3995158050730857,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,0.4060005876894226,
CK2022_2 16-1,0.5948978845222253,0.39638843430810666,
RAM2015_Log2 B,,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.5967575031803839,0.40405414746862167,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,0.593052946380538,0.42272404913558753,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.59150432025846,0.40397722720793794,
AH2018_SILAC_M_1_X,0.591740152652591,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,0.4123616119110177,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,0.5828987468581152,,
GF2025_P9_Adh,,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,,
GF2025_P3_Sph,,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,0.3979316396162625,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,,
ZQ2022_N1,,,
LY2019_P6-,,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5966639171914799,,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,0.4062428068243875,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,0.5816531849173745,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.5952761723466432,0.4025205395831703,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.5966780758432813,0.4044553127893806,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.6046010492686256,0.4127788532833012,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,
EP2017_Pervanadate R#3 log2 ratio,,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,0.5937263089418842,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,0.4143843232851818,
CK2022_6 40-1,0.5947237986346047,0.4031218874275154,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.5930915167774994,,
LY2019_P3-,,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.595647609023975,0.40372921120051986,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,,,
AST2020_Control.1,0.597690522775201,0.40821135521215696,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.596891218109111,0.40475351048694674,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.5982146138864853,0.4216625927895792,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,0.4093420620778769,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.5924492144718132,,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.5872087209178591,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.595773998753803,0.4040683406489435,
AST2020_Control.2,0.598295510014579,0.4069424155661764,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,0.5888235524365786,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.5956223669496056,0.40207751724186946,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,,
AH2018_TMTMS3_3_N,,0.40768935867011435,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,,
KBE2022_Log2_Ex_36_T,,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.5965304135464556,0.40398193037204405,
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.5920483272395659,,
CK2022_9 200-1,0.595780866526778,0.39934849599883765,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.5959760368480866,0.3994704470178783,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.5885203415912921,,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.5970712320370125,0.4054648276357223,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5835465636271302,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,0.5927522046876911,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,0.5953801295207276,0.40636554724626406,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5958150902814713,0.4036526263760572,
KBE2022_Log2_Ex_29_U,,,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,0.3984125040761318,
CK2022_15 200-1,0.618698382445207,0.4384288226744923,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.5978667034301473,0.3980216614180293,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.5968232152545698,0.4048042704854766,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,,0.396971725562849,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.5959201195375768,0.40348844631761616,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,0.5936892352938883,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,0.597329439656799,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,,,
AH2018_SILAC_M_3_C,,0.40049206207446614,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,0.4039283374758659,
AH2018_SILAC_M_2_X,,0.3930647673495258,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.5924931135325879,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.5966738029715498,0.4031547862914421,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.5973908500240157,0.42473918236916786,
CK2022_15 16-1,0.608728660944409,0.41669409399006063,
CK2022_3 16-1,0.5944902891667104,0.39204598685575187,
LY2019_P4-,,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,,
CK2022_10 16-1,0.5948678147840011,0.3940924823063851,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,,
EJN2021_2_Ex_Basal,,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,
AR2021_L41 10 μM,,,
CF2017_EOC 2,,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,0.5943486624336564,0.39775461227301917,
ZX2022_CB treated Replicate 1,,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.6067071548919684,0.4052515693820401,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.5967432505081302,0.42435841784340916,
AR2021_L41 1 μM,,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.5975635891729594,0.42276906952489834,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,0.6167880108599114,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,0.3921519114693467,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,,0.4082928797586785,
WZ2023_Pu_025_10min,0.5967157246894552,0.4037306101048016,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,0.5866247277454582,,
FSO2013_Ratio M/L normalized Rep3___1,,,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.5959838663177531,0.4039452872798644,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,0.4094761937192647,
KS2014_Intensity C6,,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.5980995924770884,0.40352134644522514,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.6047055563571214,0.41278777559766766,
AH2018_SILAC_IT_2_C,,0.40925579585156135,
CK2022_5 40-1,0.5947661513884913,0.4021724244358378,
AH2018_LFQ_3_X,,,
UK2020_UA_3,,,
LY2019_P7-,,,
GF2025_P5_Adh,,,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,0.598641406107284,0.424543090299286,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,0.5986424735013143,0.39933441169223466,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.5971990895735898,,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,0.5891774789671753,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,,0.39873036030085335,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,0.6090736056780567,0.41479700198669667,
AST2020_anti-CD3+PDL2,0.5963877739410726,0.4037093335291743,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,0.40703520475647537,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,,,
AH2018_TMTMS2_1_X,0.5969207798377782,0.4253031100484127,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,0.5915839859363129,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,0.5907490743391058,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,,0.41308675645095505,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,,0.4073299929299651,
EP2017_Untreated R#2 normalized log2 ratio,,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
